Ocuflox (Ofloxacin)

Ofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication. This interference prevents bacterial cell division, leading to bacterial death and resolution of the ocular infection.

The dosing regimen for Ocuflox is determined by the prescribing eye care professional based on the severity of the infection, patient age, and clinical response. Patients should follow the specific instructions provided by their healthcare provider.

Safety data for ofloxacin ophthalmic use in pregnancy or lactation are limited. The prescriber should weigh potential benefits against risks and consider alternative treatments if there are concerns about fetal or infant exposure.

To order Ocuflox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ocuflox (ofloxacin) belongs to the fluoroquinolone class, offering broad‑spectrum coverage against Gram‑negative and Gram‑positive bacteria. Compared with older agents like chloramphenicol, fluoroquinolones generally have higher potency and lower resistance rates, but selection should be guided by local antibiograms and patient tolerance.

Ocuflox should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from light, and avoid exposure to moisture to maintain stability and efficacy.

Ocuflox is applied topically to the affected eye(s) as directed by the prescriber, typically using a dropper to place the recommended number of drops at specified intervals. Patients should wash their hands before and after administration and avoid touching the dropper tip to the eye or any surface.

Serious risks include severe allergic reactions, corneal ulceration, vision loss, and rare systemic hypersensitivity such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience intense eye pain, worsening redness, swelling, or any signs of an allergic response.

Ocuflox should not be used by individuals with a known hypersensitivity to ofloxacin, other fluoroquinolones, or any component of the formulation. It is also contraindicated in patients with active corneal epithelial defects unless specifically directed by an eye care professional.